Cidara Therapeutics, Inc. (CDTX)
NASDAQ: CDTX · Real-Time Price · USD
23.22
+0.71 (3.15%)
Dec 20, 2024, 4:00 PM EST - Market closed
Cidara Therapeutics Employees
Cidara Therapeutics had 69 employees as of December 31, 2023. The number of employees decreased by 4 or -5.48% compared to the previous year.
Employees
69
Change (1Y)
-4
Growth (1Y)
-5.48%
Revenue / Employee
$647,145
Profits / Employee
-$1,749,754
Market Cap
254.00M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Aurora Cannabis | 1,073 |
Anika Therapeutics | 357 |
BGM Group | 298 |
Pulmonx | 279 |
Electromed | 174 |
Nautilus Biotechnology | 167 |
Heron Therapeutics | 126 |
Artiva Biotherapeutics | 43 |
CDTX News
- 4 weeks ago - Cidara: Potential To Change Flu Prophylaxis Landscape With CD388 - Seeking Alpha
- 4 weeks ago - Cidara Therapeutics Announces $105 Million Private Placement - GlobeNewsWire
- 4 weeks ago - Cidara Therapeutics to Participate in Evercore 7th Annual HealthCONx Conference - GlobeNewsWire
- 6 weeks ago - Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 7 weeks ago - Cidara Therapeutics to Participate in Two Upcoming November Investor Conferences - GlobeNewsWire
- 2 months ago - Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) - GlobeNewsWire
- 3 months ago - Cidara Therapeutics Announces Two Presentations on Innovative Drug-Fc Conjugate, CD388, at the 2024 OPTIONS XII for the Control of Influenza Conference - GlobeNewsWire
- 3 months ago - Cidara Therapeutics Announces First Subjects Dosed in Phase 2b NAVIGATE Trial Evaluating CD388 for the Prevention of Seasonal Influenza - GlobeNewsWire